Evaluating Location of Biopsy Procurement in Active Crohn*s Disease

Evaluating Location of Biopsy Procurement in Active Crohn*s Disease - RP1602

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43265

Enrollment

Registered

2016-08-29

Start date

2016-09-14

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease inflammatory bowel disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Male or females, 18 years of age or older. (2) Histologically confirmed Crohn*s disease (L1, L2 or L3) prior to study ileo-colonoscopy (3) Not on systemic anticoagulation therapy including warfarin or novel oral anticoagulants (4) Ability of subject to participate fully in all aspects of this clinical trial. (5) Written informed consent must be obtained and documented. (6) A single ulcer > 0.5 cm at study ileo-colonoscopy

Exclusion criteria

Exclusion criteria: Pregnant Women

Countries

Netherlands

Outcome results